You are not currently logged in.
Access JSTOR through your library or other institution:
If You Use a Screen ReaderThis content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Identification of Id4 as a Regulator of BRCA1 Expression by Using a Ribozyme-Library-Based Inverse Genomics Approach
Carmela Beger, Leigh N. Pierce, Martin Krüger, Eric G. Marcusson, Joan M. Robbins, Piri Welcsh, Peter J. Welch, Karl Welte, Mary-Claire King, Jack R. Barber and Flossie Wong-Staal
Proceedings of the National Academy of Sciences of the United States of America
Vol. 98, No. 1 (Jan. 2, 2001), pp. 130-135
Published by: National Academy of Sciences
Stable URL: http://www.jstor.org/stable/3054641
Page Count: 6
You can always find the topics here!Topics: Cells, RNA, Cell lines, Libraries, B lymphocytes, Journalism, Genes, Cell growth, Messenger RNA, Genomics
Were these topics helpful?See somethings inaccurate? Let us know!
Select the topics that are inaccurate.
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Preview not available
Expression of the breast and ovarian cancer susceptibility gene BRCA1 is down-regulated in sporadic breast and ovarian cancer cases. Therefore, the identification of genes involved in the regulation of BRCA1 expression might lead to new insights into the pathogenesis and treatment of these tumors. In the present study, an "inverse genomics" approach based on a randomized ribozyme gene library was applied to identify cellular genes regulating BRCA1 expression. A ribozyme gene library with randomized target recognition sequences was introduced into human ovarian cancer-derived cells stably expressing a selectable marker [enhanced green fluorescence protein (EGFP)] under the control of the BRCA1 promoter. Cells in which BRCA1 expression was upregulated by particular ribozymes were selected through their concomitant increase in EGFP expression. The cellular target gene of one ribozyme was identified to be the dominant negative transcriptional regulator Id4. Modulation of Id4 expression resulted in inversely regulated expression of BRCA1. In addition, increase in Id4 expression was associated with the ability of cells to exhibit anchorage-independent growth, demonstrating the biological relevance of this gene. Our data suggest that Id4 is a crucial gene regulating BRCA1 expression and might therefore be important for the BRCA1 regulatory pathway involved in the pathogenesis of sporadic breast and ovarian cancer.
Proceedings of the National Academy of Sciences of the United States of America © 2001 National Academy of Sciences